En ny rapport fra MSCI konkluderer, at en ligelig fordeling i bestyrelseslokalet mellem mænd og kvinder har lange udsigter. I det nuværende tempo forventes uligheden at fortsætte helt frem til 2038.
Rapporten konkluderer også:
- After a noticeable slowdown in 2020, the rate of growth of women on boards rebounded in 2021 and continued to recover in 2022 in both developed markets (DM) and emerging markets (EM), with the exception of the U.S. While the overall percentage of director seats held by women among U.S.-domiciled constituents of the MSCI World Index continued to increase and passed 30% in 2022, the rate of increase has slowed for the last three years.
- In June 2022, the European Union (EU) agreed to a new target — “40% of non-executive director posts should go to the under-represented sex” — to be achieved by June 2026.3 Out of the 328 constituents of the MSCI ACWI Index domiciled in the EU, nearly half (47.3%) have already reached the 40% threshold. But for 1.8% of EU-domiciled companies, the new target is likely to be too ambitious as they still lack any female directors.
- In 2022, health care surpassed other sectors both in terms of the total percentage of director positions held by women (27.3%) and the percentage of companies with at least 30% director seats held by women (45.4%).
- The percentage of female CEOs increased to 5.8% (up from 5.3%) in 2022 among companies in the MSCI ACWI Index, while the percentage of CFO positions held by women increased to 16.9% (up from 15.8%) among the same peer set. The percentage of women CFOs was the highest among EM companies (19.9%).
Læs mere her.
